Search results
Peruvian Surf Legend Gabriel Villaran Launches Crowdfunder to Support Brother’s Cancer Treatment
The Inertia via Yahoo News· 7 hours agoGabriel Villaran created a crowdfunder to help pay for treatment of his brother’s diagnosis of ...
Novartis study points to larger role for targeted leukemia drug
BioPharma Dive via Yahoo Finance· 5 days agoPeople with chronic myeloid leukemia, a simmering cancer of the bone marrow, are often treated with...
Novartis leukemia drug more effective than older treatments in trial
AOL· 5 days agoSwiss drugmaker Novartis said patients with a type of leukemia who took its Scemblix had a significantly better response and a lower dropout rate than those who received current ...
STAMP Inhibitor Tops Imatinib, Second-Gen TKIs for Newly Diagnosed CML
MedPage Today· 5 days agoThe STAMP inhibitor asciminib (Scemblix) had a statistically superior response rate compared with...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoLive from ASCO 2024 | Ascentage Pharma Releases Updated Data Showing Promising Efficacy and Safety of Lisaftoclax in Patients with WM PR Newswire SUZHOU, China, and ROCKVILLE, Md., June 4, 2024 ...
Novartis' Oral Drug For Chronic Skin Disease Candidate Shows Efficacy, Long-term Safety - Novartis...
Benzinga· 5 days agoOn Friday, Novartis AG NVS released new data that confirm the long-term efficacy and safety of...
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI...
Benzinga· 5 days agoREDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting
California State Teachers Retirement System Purchases 60,431 Shares of Bristol-Myers Squibb...
ETF DAILY NEWS· 2 days agoCalifornia State Teachers Retirement System grew its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.8% during the fourth quarter, according to its most recent 13F filing with ...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 5 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.